Fulcrum Therapeutics, Inc.

Q1 2021 13F Holders

Symbol
FULC
CUSIP
359616109
Type
Equity
Class
COM
Num filings
69
Total reported value, excl. options
$317 M
Manager Report Date Value ($000) Shares Option Type